uniQure N.V. Accounts Payable
uniQure N.V. (QURE) had Accounts Payable of $4.40 million as of 2026-03-31, per its 10-Q filed 2026-05-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-05-05
- 2026-03-31: Accounts Payable, Current $4.40M.
- 2025-12-31: Accounts Payable, Current $5.17M.
- 2025-09-30: Accounts Payable, Current $6.23M.
- 2025-06-30: Accounts Payable, Current $5.54M.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-03-31 | $4.40M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $5.17M 10-Q · filed 2026-05-05 |
| 2025-09-30 | $6.23M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $5.54M 10-Q · filed 2025-07-29 |
| 2025-03-31 | $5.27M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $7.23M 10-K · filed 2026-03-02 |
| 2024-09-30 | $5.44M 10-Q · filed 2024-11-05 |
| 2024-06-30 | $4.41M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $5.23M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $6.59M 10-K · filed 2025-02-27 |
| 2023-09-30 | $5.58M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $9.37M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $8.88M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $10.98M 10-K · filed 2024-02-28 |
| 2022-09-30 | $7.57M 10-Q · filed 2022-11-02 |
| 2022-06-30 | $10.03M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $9.92M 10-Q · filed 2022-05-02 |
| 2021-12-31 | $2.50M 10-K · filed 2023-02-27 |
| 2021-09-30 | $5.37M 10-Q · filed 2021-10-25 |
| 2021-06-30 | $16.82M 10-Q · filed 2021-07-26 |
| 2021-03-31 | $5.75M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $3.77M 10-K · filed 2022-02-25 |
| 2020-09-30 | $2.35M 10-Q · filed 2020-10-27 |
| 2020-06-30 | $4.94M 10-Q · filed 2020-07-30 |
| 2020-03-31 | $4.99M 10-Q · filed 2020-04-29 |
| 2019-12-31 | $5.68M 10-K · filed 2021-03-01 |
| 2019-09-30 | $3.78M 10-Q · filed 2019-10-28 |
| 2019-06-30 | $4.52M 10-Q · filed 2019-07-29 |
| 2019-03-31 | $3.53M 10-Q · filed 2019-04-29 |
| 2018-12-31 | $3.79M 10-K · filed 2020-03-02 |
| 2018-09-30 | $4.12M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $3.87M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $3.69M 10-Q · filed 2018-04-30 |
| 2017-12-31 | $2.91M 10-K · filed 2019-02-28 |
| 2017-09-30 | $2.99M 10-Q · filed 2017-11-01 |
| 2017-06-30 | $3.46M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $3.95M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $5.52M 10-K · filed 2018-03-14 |
| 2015-12-31 | $4.06M 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |